Fortress Biotech, Inc. (FBIO) — Stock Score Summary

Fortress Biotech, Inc. (FBIO) has a MoatMap StockRank of 31/100 based on Quality (25/100), Value (58/100), and Momentum (35/100) factor scores. The current signal is SELL. Fortress Biotech is a biopharmaceutical business builder that acquires and develops clinical-stage assets. It is a highly speculative, cash-burning entity that lacks the stable cash flows, high ROIC, and structural moats of our quality compounder philosophy.

Fortress Biotech, Inc. is a biopharmaceutical company that utilizes a unique business model focused on acquiring, developing, and commercializing clinical-stage drug candidates. The company's competitive moat lies in its specialized business development engine, which identifies and acquires undervalued pharmaceutical assets to be developed through its network of subsidiary companies. It operates as a diversified biotech incubator, generating revenue from commercialized products while maintaining significant upside from its extensive clinical pipeline.

Key Financial Metrics

Price$2.93
Market Cap$93M
P/E (TTM)0.92
P/E (Forward)-1.69
Price/Book1.87
Return on Equity-108.7%
Return on Invested Capital-18.3%
Debt/Equity108.09
Gross Margin48.1%
Operating Margin-29.8%
Revenue Growth6.3%
Free Cash Flow$-47M

Fortress Biotech, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Fortress Biotech, Inc.’s (FBIO) StockRank?
MoatMap’s StockRank for Fortress Biotech, Inc. (FBIO) is 31/100, with a Sell signal. It is a composite of Quality (25), Value (58), and Momentum (35) factor ranks across MoatMap’s 19,000+ stock universe.
Does Fortress Biotech, Inc. have an economic moat?
Fortress Biotech, Inc. (FBIO) has a Quality factor score of 25/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Fortress Biotech, Inc. a buy, hold, or sell?
MoatMap’s current signal for Fortress Biotech, Inc. (FBIO) is Sell, based on a StockRank of 31/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Fortress Biotech, Inc. in?
Fortress Biotech, Inc. (FBIO) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksFBIO deep dive reportAI ChampionsHow we score stocksSense-check another stock